Navigation Links
ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
Date:3/18/2011

an unmet medical need, and providing rewarding careers to employees.  ViroPharma commercializes Cinryze® (C1 esterase inhibitor [human]) in the U.S. for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema (HAE).  ViroPharma commercializes Vancocin®, approved in the U.S. for oral administration for treatment of antibiotic-associated pseudomembranous colitis caused by Clostridium difficile and enterocolitis caused by Staphylococcus aureus, including methicillin-resistant strains (for prescribing information on ViroPharma's commercial products, please download the package inserts at http://www.viropharma.com/Products.aspx).  ViroPharma currently focuses its drug development activities in diseases including C1 esterase inhibitor deficiency and C. difficile infection.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's website, http://www.viropharma.com/. The company encourages investors to consult these sections for more information on ViroPharma and our business.

Forward Looking Statements

Certain statements in this press release contain forward-looking statements that involve a number of risks and uncertainties. Forward-looking statements provide our current expectations or forecasts of future events, including our regulatory filings in Europe related to Cinryze, including without limitation statements related to potential regulatory timelines, the likelihood of regulatory success including our ability to address the questions regarding our relationship with Sanquin and the scope of indications for which Cinryze may be approved. The EC may view the data regarding the use of Cinryze for acute treatment and / or prevention of HAE we hav
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. ViroPharma to Present at Three Upcoming Healthcare Conferences
2. ViroPharma to Present at the Natixis Bleichroeder Conference
3. ViroPharma To Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. ViroPharma to Release 2008 First Quarter Financial Results on April 30, 2008
5. ViroPharma Announces Discontinuation of HCV-796 Development
6. ViroPharma Announces Completion of Enrollment in Phase 3 Study of Maribavir in Stem Cell Transplant Patients
7. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
8. ViroPharma Announces Presentation of Cinryze(TM) Data in Acute Treatment of Hereditary Angioedema
9. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
10. ViroPharma Submits Comments on Vancocin(R) Draft Bioequivalence Guidance
11. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... ANGELES , Aug. 29, 2014  Chuma ... both financing alternatives and turnkey support services for ... announce that FINRA processed and approved the Company,s ... 29, 2014, CannaMed Corporation will be known as ... change was accomplished through a merger with the ...
(Date:8/29/2014)... The Competitive Intelligence (CI) function is evolving ... leaders who adjust will succeed, and those who don,t ... Practices, LLC study CI leaders from 32 biopharmaceutical organizations ... - Use secondary research whenever possible - it,s effective, ... Internal staff who are creative thinkers provide the CI ...
(Date:8/29/2014)... 2014 Pomerantz LLP has filed a class ... (NASDAQ: EDAP ) and certain of its ... Court, Southern District of New York ... a class consisting of all persons or entities who ... 30, 2014, inclusive (the "Class Period"). This class action seeks ...
Breaking Medicine Technology:CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3
... Inc. (pronounced dot decimal), an innovative manufacturer of patient-specific ... 510(k) clearance from the FDA to market electron apertures ... now available to radiation oncology centers across the U.S. ... known as electron ,cutouts, by radiation therapy departments -- ...
... - Digital issue looks inside the minds, lives ... Journal of Emergency Medical Services ( JEMS ) ... issue featuring first-person accounts of responders who were thrust into ... terrorists invaded their response districts - and their lives - ...
Cached Medicine Technology:Florida Medical Device Manufacturer Announces New Product Release for Radiation Therapy 2Out of the Darkness 2Out of the Darkness 3
(Date:9/1/2014)... Albany, New York (PRWEB) September 01, 2014 ... to store, retrieve, organize and analyze biological and ... comprises of the activity of developing software tools ... is not to be confused with biological computation. ... the better understanding of biology can its related ...
(Date:9/1/2014)... 01, 2014 Registration is now open for ... and 1-Mile Race to be held on Sunday, September 21, ... Yard at Harmon Meadow in Secaucus, New Jersey. All proceeds ... national nonprofit dedicated to restoring a sense of self, restoring ... and our military families. , General registration is $30 with ...
(Date:9/1/2014)... Daily Gossip reveals in it's review on Tattoo ... members access to thousands of professionally designed tattoo images ... to help both people who plan on getting a ... for inspiration in creating one of a kind models. ... visiting the official website at: http://www.dailygossip.org/atattoo-me-now-6444 . , ...
(Date:9/1/2014)... Pastor Thompson is an ordained minister and previously ... is a licensed minister through the Church of the Nazarene ... in New Mexico, Colorado and North Dakota. He and his ... He also has two beautiful daughters, Brianna, 22 and ... from Nazarene Bible College, in Colorado Springs and is currently ...
(Date:9/1/2014)... Psychogenic Non-epileptic Seizures (PNES), also known ... that can have devastating effects on those who develop ... however, they are not produced by electrical anomalies in ... is estimated that the numbers of persons suffering PNES ... , Dr. Lorna Myers, Director of the ...
Breaking Medicine News(10 mins):Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Tattoo Me Now Review Reveals Unique Ideas for Tattoo Designs 2Health News:The Northeast Regional Epilepsy Group (NEREG) Offers First Conference on Psychogenic Non-epileptic Seizures (PNES) on September 20, 2014 in New Jersey 2
... American Association of Anatomist,s (AAA) presented its highest awards ... Washington, DC. This year,s honors went to: ... at Harvard Medical School, Professor of Developmental Biology and ... Medicine Olsen received the 2011 Henry Gray/ Lippincott Williams ...
... , MONDAY, April 25 (HealthDay News) -- Some college students ... reruns during the TV writers, strike of 2007-2008, a new ... use television for companionship -- as opposed to simply for ... characters on the tube, the study authors noted. "We ...
... Cancer has a mighty big bag of tricks that it ... Among those tricks is one that allows tumor cells to ... something of a highway to metastasis. Yet research unveiled this ... put the brakes on such cancer spread, and the researchers ...
... the same time can be especially difficult for persons who,ve ... -- measured by a simple radar system -- to quickly ... asking an individual to walk a short distance while saying ... the Georgia Tech Research Institute (GTRI) can determine if that ...
... (HealthDay News) -- Acupuncture might help reduce the hot ... on hormone therapy, a small study suggests. ... relieves hot flashes, and only 14 men participated in ... York Methodist Hospital and Weill Cornell Medical College of ...
... , FRIDAY, April 22 (HealthDay News) -- Patients ... a six-fold increased risk of death if they become ... study finds. IBD includes Crohn,s disease and ulcerative ... often require hospitalization, note the researchers at Imperial College ...
Cached Medicine News:Health News:Some TV Fans 'Distressed' Without Favorite Shows: Study 2Health News:Laying bare the not-so-sweet tale of a sugar and its role in the spread of cancer 2Health News:Laying bare the not-so-sweet tale of a sugar and its role in the spread of cancer 3Health News:Radar shows promise for detecting concussions in athletes and soldiers 2Health News:Radar shows promise for detecting concussions in athletes and soldiers 3Health News:Acupuncture May Help Ease Hot Flashes Tied to Prostate Cancer Treatment 2Health News:Hospital Infection Raises Death Risk for Bowel Patients 2
The Vitatron Slimtine S lead series are endocardial leads with an excellent history of reliability and optimal handling en pacing performance....
Bipolar Atrial "J" Lead...
Unipolar temporary atrial pacing lead is smaller and thinner than Medtronics standard temporary pacing leads. It is well suited for thin, delicate, atrial tissue....
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),...
Medicine Products: